In these countries, the finding that, on average, and when used continuously, sulfonylureas medications appeared to be more effective than DDP4 inhibitors is also useful information.
How much do your programs cost
Moreover, in 2025, Eli Lilly became the first pharmaceutical company in history to reach a US$1 trillion market valuation, joining a club historically dominated by technology firms
Cost and accessibility have been cited as the main barriers to their use, although there have been other issues moderating their uptake
It demands commitment to lifestyle changes, consistent medication use, and ongoing medical supervision to monitor progress and adjust treatment as needed